Benzothiazole derivatives for the treatment of diabetes

Details for Australian Patent Application No. 2004271740 (hide)

International Classifications

Event Publications

16 February 2006 PCT application entered the National Phase

PCT publication WO2005/025567 Priority application(s): WO2005/025567

25 October 2007 Assignment before Grant

Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

23 April 2009 Alteration of Name

The name of the applicant has been altered to Merck Serono SA

3 September 2009 Section 223 Application Received

Merck Serono SA An application to extend the time from 20 May 2008 to 20 Jun 2009 in which to request examination has been filed . Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 2007

22 October 2009 Section 223 Application Allowed

Merck Serono SA The time in which to request examination has been extended to 20 Jun 2009. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

28 October 2010 Application Accepted

Published as AU-B-2004271740

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.